As we enter a new year, it’s essential to reflect on the milestones achieved in marijuana law reform over the past year. The landscape of cannabis legislation has evolved significantly, yet the path to comprehensive reform remains intricate and slow-moving. In 2019, we witnessed pivotal changes mainly across Europe, shedding light on the global attitudes towards marijuana.
In February, Switzerland took a significant step forward by announcing its plans to allow up to 5,000 participants to legally consume marijuana in pilot studies. This initiative aims to gather data that would inform future regulations concerning recreational use. It’s a fascinating model that could pave the way for a more permissive approach across other European nations.
Meanwhile, the Netherlands addressed the longstanding “back-door problem” in August. Although marijuana sales were legal, there was no lawful source for its supply. The government announced a pilot program slated to begin in 2021, supplying cannabis cafes in ten cities with legally grown marijuana. However, major cities like Amsterdam and Rotterdam decided to opt out, concerned about potential disruptions with illicit suppliers.
In August, Luxembourg confirmed its intention to become the first European country to legalize cannabis, allowing residents aged 18 and over to use and purchase it in the following two years. Nevertheless, by December, the government indicated that due to “delays in working on policy relating to the legislation,” the timeline would be pushed back at least two years.
Additionally, in September, the city council of Copenhagen voted overwhelmingly to support a pilot program for legal marijuana sales throughout the city. The newly elected left-wing government could further buoy this initiative, reflecting a shift towards more liberal cannabis policies.
In December, Italy’s Supreme Court ruled that individuals may legally cultivate small amounts of marijuana for personal use, potentially opening the floodgates for enhanced legalization discussions nationwide.
In April, Israel decriminalized the possession of marijuana, signaling a change in public perception of cannabis. While private possession became non-offensive, public possession resulted in a fine, indicating a move towards a more measured approach to cannabis legality.
Beyond Europe, Australia saw Canberra, its capital, legalize personal use and cultivation of cannabis, although sales remain prohibited. The national capital became the first to allow up to 50 grams and two plants per person, challenging the overarching national ban. Similarly, New Zealand announced plans for a binding referendum on marijuana legalization in its upcoming elections, signaling growing public support for cannabis decriminalization.
In the Western Hemisphere, countries like Uruguay and Canada have held leading positions in marijuana legalization, and the spotlight shifted to Mexico, which was poised to be the next in line for comprehensive legalization. Although negotiations stalled at the end of October, the Supreme Court extended the timeline for legislative action, emphasizing the urgency of reform.
The Caribbean also witnessed shifts, with Trinidad and Tobago passing non-commercial legalization, allowing individuals to possess up to 30 grams and cultivate up to four plants, while St. Kitts and Nevis proposed a bill to legalize marijuana for a wide range of uses, reflecting a broader acceptance of cannabis within the region.
On the medical marijuana front, the acceptance rate skyrocketed. In January, Israel’s government approved medical marijuana exports, joining Canada and the Netherlands in expanding its international medical cannabis trade. The European Parliament also took significant steps, advancing medical marijuana’s status within member states. Countries like Peru finally approved regulations for medical cannabis, following a lengthy delay.
In the international sphere, the World Health Organization recommended the removal of marijuana from the strictest category of the global drug treaties, igniting discussions about its medicinal use globally. This significant acknowledgment from a leading health authority speaks to the changing narrative around cannabis.
Despite the progress, the pace of reform remains uneven, marked by incremental changes rather than sweeping laws. Each reform effort builds upon the last, creating a complex mosaic of marijuana legislation worldwide. As we continue this journey, it’s evident that the momentum for marijuana law reform is far from over, with a vibrant dialogue emerging around its medicinal and recreational use.